DE3866390D1 - Pharmazeutische zubereitungen von acrivastine. - Google Patents

Pharmazeutische zubereitungen von acrivastine.

Info

Publication number
DE3866390D1
DE3866390D1 DE8888302658T DE3866390T DE3866390D1 DE 3866390 D1 DE3866390 D1 DE 3866390D1 DE 8888302658 T DE8888302658 T DE 8888302658T DE 3866390 T DE3866390 T DE 3866390T DE 3866390 D1 DE3866390 D1 DE 3866390D1
Authority
DE
Germany
Prior art keywords
acrivastine
pharmaceutical preparations
formulations
copolymer
acrylic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8888302658T
Other languages
English (en)
Inventor
Harry Phillip Jones
Robert Judson Mackey
Michael John Desmond Gamlen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Application granted granted Critical
Publication of DE3866390D1 publication Critical patent/DE3866390D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE8888302658T 1987-03-27 1988-03-25 Pharmazeutische zubereitungen von acrivastine. Expired - Lifetime DE3866390D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878707416A GB8707416D0 (en) 1987-03-27 1987-03-27 Pharmaceutical formulations

Publications (1)

Publication Number Publication Date
DE3866390D1 true DE3866390D1 (de) 1992-01-09

Family

ID=10614818

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888302658T Expired - Lifetime DE3866390D1 (de) 1987-03-27 1988-03-25 Pharmazeutische zubereitungen von acrivastine.

Country Status (21)

Country Link
US (2) US4954350A (de)
EP (1) EP0284408B1 (de)
JP (1) JP2753297B2 (de)
KR (1) KR960006067B1 (de)
AT (1) ATE69725T1 (de)
AU (1) AU606149B2 (de)
CA (1) CA1303504C (de)
DE (1) DE3866390D1 (de)
DK (1) DK175660B1 (de)
ES (1) ES2027005T3 (de)
FI (1) FI92904C (de)
GB (1) GB8707416D0 (de)
GR (1) GR3003224T3 (de)
HU (1) HU202102B (de)
IE (1) IE61166B1 (de)
IL (1) IL85872A (de)
NO (1) NO175618C (de)
NZ (1) NZ224024A (de)
PT (1) PT87082B (de)
WO (1) WO1988007369A1 (de)
ZA (1) ZA882167B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2558396B2 (ja) * 1990-06-28 1996-11-27 田辺製薬株式会社 放出制御型製剤
US5188836A (en) * 1990-07-27 1993-02-23 Warner-Lambert Company Sustained release formulations
EP0520119A1 (de) * 1991-06-17 1992-12-30 Spirig Ag Pharmazeutische Präparate Neue orale Diclofenaczubereitung
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5472712A (en) * 1991-12-24 1995-12-05 Euroceltique, S.A. Controlled-release formulations coated with aqueous dispersions of ethylcellulose
US5681585A (en) 1991-12-24 1997-10-28 Euro-Celtique, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
US7070806B2 (en) * 1992-01-27 2006-07-04 Purdue Pharma Lp Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5514655A (en) * 1993-05-28 1996-05-07 Abbott Laboratories Enteral nutritional with protein system containing soy protein hydrolysate and intact protein
US6103262A (en) * 1994-01-27 2000-08-15 G. D. Searle & Company Modified-release metronidazole compositions and methods for making and using same
US6245351B1 (en) 1996-03-07 2001-06-12 Takeda Chemical Industries, Ltd. Controlled-release composition
WO1998052566A1 (en) * 1997-05-21 1998-11-26 Warner-Lambert Company Non-sedating acrivastine preparation
WO1999001111A1 (en) 1997-07-02 1999-01-14 Euro-Celtique, S.A. Stabilized sustained release tramadol formulations
JP2000128776A (ja) * 1998-10-19 2000-05-09 Asahi Chem Ind Co Ltd フィルムコーティング顆粒およびその製造方法
JP4711472B2 (ja) * 1998-10-20 2011-06-29 旭化成ケミカルズ株式会社 フィルムコーティング顆粒
FR2790668B1 (fr) * 1999-03-12 2002-07-26 D B F Granules contenant une substance vegetale et leur procede de preparation
US7041317B2 (en) 2000-10-23 2006-05-09 Ono Pharmaceutical Co., Ltd. Sustained-release preparation containing 5-acetyl-4,6-dimethyl-2[2-[4-(2-methoxyphenyl) piperazinyl]ethylamino] pyrimidine trihydrochloride as active ingredient
AU2002248792B2 (en) * 2001-04-18 2006-09-21 Nostrum Pharmaceuticals Inc. A novel coating for a sustained release pharmaceutical composition
PT1476138E (pt) * 2002-02-21 2012-02-14 Valeant Internat Barbados Srl Formulações de libertação modificada de pelo menos uma forma de tramadol
EP1526843A1 (de) * 2002-07-25 2005-05-04 Pharmacia Corporation Verfahren zur herstellung fester dosierformen mit einem zweischichtigen überzug aus einem wasserunlöslichen polymer und einem wasserlöslichen porenbildner
JP5649784B2 (ja) * 2006-02-07 2015-01-07 エフ エム シー コーポレーションＦｍｃ Ｃｏｒｐｏｒａｔｉｏｎ 組成物、基材を組成物でコーティングする方法、被覆基材、製品、フィルム、ペレット、タブレット及びカプセル
US8309129B2 (en) 2007-05-03 2012-11-13 Bend Research, Inc. Nanoparticles comprising a drug, ethylcellulose, and a bile salt
US8703204B2 (en) 2007-05-03 2014-04-22 Bend Research, Inc. Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and anon-ionizable polymer
US8974827B2 (en) 2007-06-04 2015-03-10 Bend Research, Inc. Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
WO2008149230A2 (en) 2007-06-04 2008-12-11 Pfizer Products Inc. Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate
JP5283623B2 (ja) * 2007-07-17 2013-09-04 旭化成ケミカルズ株式会社 水系組成物
EP2231169B1 (de) 2007-12-06 2016-05-04 Bend Research, Inc. Pharmazeutische zusammensetzungen mit nanopartikeln und resuspensionsmaterial
US9233078B2 (en) 2007-12-06 2016-01-12 Bend Research, Inc. Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer
BR112013021391A2 (pt) * 2011-02-23 2016-10-18 Intercontinental Great Brands Llc pré-misturas de sabor para goma de mascar, métodos para fazer pré-misturas de sabor e composições de goma de mascar das mesmas
CA2758556A1 (en) * 2011-11-17 2013-05-17 Pharmascience Inc. Pharmaceutical composition of amphetamine mixed salts
CA2936746C (en) 2014-10-31 2017-06-27 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0052075A1 (de) * 1980-11-12 1982-05-19 Ciba-Geigy Ag Körnige Arzneimittel-Retardform
EP0052076B1 (de) * 1980-11-12 1985-05-29 Ciba-Geigy Ag Schnellzerfallende Arzneimittel-Presslinge
YU44821B (en) * 1982-02-04 1991-02-28 Wellcome Found Process for obtaiing new pyridyl derivatives
US4562258A (en) * 1982-02-04 1985-12-31 Findlay John W A 6-[3-Amino-1-(4-tolyl)prop-1E-enyl]pyridine-2-carboxylic acid derivatives having antihistaminic activity
DE3314003A1 (de) * 1983-04-18 1984-10-18 Boehringer Ingelheim KG, 6507 Ingelheim Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung
LU85058A1 (fr) * 1983-10-24 1985-06-19 Pharlyse Comprimes pharmaceutiques a liberation prolongee,leur preparation et leur utilisation
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
IE59287B1 (en) * 1984-02-10 1994-02-09 Benzon Pharma As Diffusion coated multiple-units dosage form
CH658188A5 (de) * 1984-03-23 1986-10-31 Ciba Geigy Ag Lagerstabile schnellzerfallende pharmazeutische presslinge.
US4783465A (en) * 1984-04-09 1988-11-08 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4871733A (en) * 1984-04-09 1989-10-03 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
GB2159715B (en) * 1984-06-04 1988-05-05 Sterwin Ag Pharmaceutical composition in sustained release unit dose form and process for its preparation
US4728512A (en) * 1985-05-06 1988-03-01 American Home Products Corporation Formulations providing three distinct releases
EP0205336B1 (de) * 1985-06-11 1991-09-11 Teijin Limited Oral-Arzneizubereitung mit Retardwirkung
GB8519310D0 (en) * 1985-07-31 1985-09-04 Zyma Sa Granular active substances
EP0212745B1 (de) * 1985-08-16 1991-04-10 The Procter & Gamble Company Partikel mit konstanter Wirkstofffreisetzung
JPS6261916A (ja) * 1985-09-12 1987-03-18 Fujisawa Pharmaceut Co Ltd 持続性製剤
US4693896A (en) * 1985-10-07 1987-09-15 Fmc Corporation Ethylcellulose-coated, gastric-disintegrable aspirin tablet
SE450087B (sv) * 1985-10-11 1987-06-09 Haessle Ab Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial
IT1188212B (it) * 1985-12-20 1988-01-07 Paolo Colombo Sistema per il rilascio a velocita' controllata di sostanze attive
US4816264A (en) * 1986-06-06 1989-03-28 Warner-Lambert Company Sustained release formulations
US4810501A (en) * 1986-06-17 1989-03-07 Warner-Lambert Company Sustained release pharmaceutical preparations
IE58401B1 (en) * 1986-06-20 1993-09-08 Elan Corp Plc Controlled absorption pharmaceutical composition
ATE71293T1 (de) * 1986-09-18 1992-01-15 London Pharmacy Innovation Arzneiformulierung.
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions

Also Published As

Publication number Publication date
WO1988007369A1 (en) 1988-10-06
US5370880A (en) 1994-12-06
DK662688A (da) 1988-11-25
US4954350A (en) 1990-09-04
PT87082A (pt) 1988-04-01
ATE69725T1 (de) 1991-12-15
JPH01502754A (ja) 1989-09-21
IE61166B1 (en) 1994-10-05
JP2753297B2 (ja) 1998-05-18
GR3003224T3 (en) 1993-02-17
KR960006067B1 (ko) 1996-05-08
CA1303504C (en) 1992-06-16
EP0284408A1 (de) 1988-09-28
IE880901L (en) 1988-09-27
NO885123L (no) 1988-11-16
IL85872A (en) 1992-03-29
NO175618C (no) 1994-11-09
DK175660B1 (da) 2005-01-10
GB8707416D0 (en) 1987-04-29
ZA882167B (en) 1989-11-29
ES2027005T3 (es) 1992-05-16
NO175618B (de) 1994-08-01
FI92904C (fi) 1995-01-25
PT87082B (pt) 1992-07-31
NO885123D0 (no) 1988-11-16
HU202102B (en) 1991-02-28
FI885460A0 (fi) 1988-11-24
NZ224024A (en) 1990-06-26
DK662688D0 (da) 1988-11-25
KR890700344A (ko) 1989-04-24
IL85872A0 (en) 1988-09-30
AU606149B2 (en) 1991-01-31
AU1496788A (en) 1988-11-02
FI885460A (fi) 1988-11-24
EP0284408B1 (de) 1991-11-27
FI92904B (fi) 1994-10-14
HUT50627A (en) 1990-03-28

Similar Documents

Publication Publication Date Title
DE3866390D1 (de) Pharmazeutische zubereitungen von acrivastine.
HUT56267A (en) Process for producing pharmaceutical compositions having controlled release of active ingredient
KR880010759A (ko) 방출 조절성 제제
ES2080796T3 (es) Formulaciones de productos farmaceuticos de liberacion prolongada.
MA21182A1 (fr) Ester 2,3,5,6-tetrafluorobenzylique d'acide (+) 1r-trans-2,2-dimeghyl-3-(2,2 dichlorovinyl) -cyclopropane-carboxylique, son procede de preparation et composition insecticide le contenant.
ES2071621T3 (es) Enantiomero dextrogiro del alfa-(tetrahidro-4,5,6,7-tieno-(3,2-c)-piridil-5)(cloro-2-fenil) acetato de metilo, su procedimiento de preparacion y las composiciones farmaceuticas que lo contienen.
DE69206214T2 (de) Neue Arylethylaminderivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen.
PT90308A (pt) Processo para a preparacao de composicoes farmaceuticas contendo azelastina com libertacao controlada da substancia activa
ATE4411T1 (de) Prostaglandin-verbindungen enthaltende pharmazeutische praeparate und verfahren zu deren herstellung.
TH5433EX (th) สูตรผสมในทางเภสัชกรรมของแอไครแวสทีน
ATE104848T1 (de) Trapidil enthaltende pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung.
AT342761B (de) Verfahren zur herstellung von homopyrimidazol-derivate enthaltenden, stabilen pharmazeutischen praparaten zur oralen verabreichung
DE68928788T2 (de) Verfahren zur Herstellung von optisch aktiven 3,4-Dihydroxybuttersäurederivaten
AR002736A1 (es) Uso de ester 3-metil-5-etilico de acido 2,6-dimetil-4-(2,3-diclorofenil-1,4 -dihidropiridin-3,5-dicarboxilico (felodipina) para fabricar un medicamento ypreparacion farmaceutica para el tratamiento de la disfuncion cerebral.
TH5433A (th) สูตรผสมในทางเภสัชกรรมของแอไครแวสทีน
TH4604B (th) สูตรผสมในทางเภสัชกรรมของแอไครแวสทีน
ATE53993T1 (de) 1,4-dihydropyridincarbonsaeure-ester, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition